Working Groups

//
Working Groups
Working Group 1

WG1 - Study Populations and Expertise Groups

The objective of this Working Group is to create, maintain an update the studies and group of experts conforming the network. The European research groups will be central to these organizations but will also reach to an international setting in the Americas and Australasian regions, procuring to maximize the enrichment of the network.
Working Group 2

WG2 – Phenotyping

The objective of this Working Group will be to describe ways to decompose the phenotypes of the different genetic studies into meaningful components that will aid the interpretation of the identified biological pathways.
Working Group 3

WG3 – Monogenic Conditions- human KO Models

The objective of this Working Group up will initially be to make an inventory of all the genes underlying monogenic conditions presenting with a clear musculoskeletal phenotype. After this, the main focus of WG5 will be to evaluate the overlap between this list of genes and those genes characterized by WG4 and trace them back into common biological pathways.
Working Group 4

WG4 – Functional Investigations

The objective of this Working Group is to initially liaise with WG1 to make an inventory of the expertise across functional groups of the network with a trajectory on “wet lab” cell and organism models of the musculoskeletal system.
Working Group 5

WG5 – Bioinformatics

The objective of this Working Group will initially be to make an inventory of all the genetic discoveries arising from the distinct efforts. This will be followed by the integration of databases and resources from the public domain, but also those assembled from the different functional Working Groups of the network as inventoried by WG2.
Working Group 6

WG6 – Translational Outreach

The objective of this Working Group is to make a synopsis of the knowledge derived from the integration of activities and expertise provided by WG1, WG2, WG3, WG4 and WG5. In order to constitute a roadmap for the identification of drug targets by means of pinpointing molecules and factors within biological pathways that can be suitable for future investigations in a potential therapeutic context.

Participants

Aare Märtson
Estonia
Alban Ylli
Albania
Aleksandra Nikolic
Serbia
Alice Costantini
Sweden
Alper Cebi
Turkey
Amina Valjevac
Bosnia and Herzegovina
Ana VASIC
Serbia
Anastasios Bezerianos
Greece
Anastasis Stephanou
Cyprus
Anders Kämpe
Sweden
André Uitterlinden
Netherlands
Angela Xuereb-Anastai
Malta
Angeles Morales Fernández
Spain
Ângelo Calado
Portugal
Anna Teti
Italy
Antonia Sophocleous
Cyprus
Antonio Maurizi
Italy
Åshild Bjørnerem
Norway
Barbara OBERMAYER-PIETSCH
Austria
Barbara Ostanek
Slovenia
Barbara Voraberger
Austria
Bayram Bayramov
Azerbaijan
Beatriz Larraz Prieto
Spain
Bendik Winsvold
Bente Langdahl
Denmark
Bert van Rietbergen
Netherlands
Björn Busse
Germany
Bledar Kraja
Albania
Bodhisattwa Banerjee
Israel
Bram van der Eerden
Netherlands
Brent Richards
Canada
Carola Zillikens
Netherlands
Celia Gregson
United Kingdom
Christoph Haudum
Austria
Claes OHLSSON
Sweden
Cyrus Cooper
United Kingdom
Daniel Grinberg
Spain
David KARASIK
Israel
Diana Crespo
Spain
Didier Hans
Switzerland
Douglas Kiel
USA
Duncan Bassett
UK
Dylan Bergen
United Kingdom
Eleni Douni
Greece
Emma Duncan
United Kingdom
Ene Reimann
Estonia
Enrique Guerado
Spain
Erika Kague
United Kingdom
Esther Wehrle
Switzerland
Eva Hassler
Austria
Evangelia NTZANI
Greece
Evangelos Evangelou
Greece
Eveline Boudin
Belgium
Evi Gkikopoulou
Greece
Fernando RIVADENEIRA
Netherlands
Fiona Mcguigan
Sweden
Fjorda Koromani
Netherlands
Francesca Marini
Italy
Francisco Martin
Spain
Gennady Roshchupkin
Netherlands
Georgina McDonald
UK
Graham Williams
United Kingdom
Gretl Hendrickx
BElgium
HJ van de Peppel
Netherlands
Inês Alves
Portugal
Ines Foessl
Austria
Ioannis Patrikios
Cyprus
Irina Naskinova
Bulgaria
Iryna Khrystoforova
Israel
Ismeta Redzic
Bosnia and Herzegovina
Ivan Duran
Spain
Ivan SOLDATOVIC
Serbia
Iveta Nikolova
Bulgaria
Janja Marc
Slovenia
Jannie Dahl Hald
Denmark
Jasna Lojk
Slovenia
Javier Bonsón
Spain
Jeroen van de Peppel
Joao Eurico Fonseca
Portugal
John Bassett
United Kingdom
John Kemp
Australia
Jose Antonio Riancho
Spain
Jose Manuel Jiménez Martin
Spain
Jose Riancho
Spain
Kaspar Tootsi
Estonia
Katerina Trajanoska
Netherlands
Kathleen Curran
Ireland
Katie Noonan
Ireland
Katre Maasalu
Estonia
Kent Søe
Denmark
Kirsi Määttä
Finland
Lars Bertram
Germany
Linda McCarthy
United Kingdom
Ling Oei
Netherlands
Luca Sangiorgi
Italy
Maria Carola Zillikens
NL
Maria Carolina Medina Gomez
Netherlands
Maria Christou
Greece
Maria Ines Almeida
Portugal
Maria Luisa BRANDI
Italy
Marija Mijovic
Serbia
Martina RAUNER
Germany
Mehraj ABBASOV
Azerbaijan
Melanija Rašić
Serbia
Melissa FORMOSA
Malta
Mikhail KOLEV
Bulgaria
Milana FRENKEL-MORGENSTERN
Israel
Natalia García Giralt
Spain
Nathan John Pavlos
Australia
Neelam Hassan
United Kingdom
Neha Sherma
Denmark
Nerea ALONSO
United Kingdom
Neus Roca Ayats
Spain
Nicholas Fuggle
United Kingdom
Nika Lovsin
Orkhan Mustafayev
Azerbaijan
Outi MÄKITIE
Finland
Patricia Khashayar
Belgium
Pawel Szulc
France
Philippe Lopes
France
Ralph Müller
Switzerland
Riikka Mäkitie
Finland
Riku Kiviranta
Finland
Samuel Ghatan
Netherlands
Şansın TÜZÜN
Turkey
Sara Moura
Portugal
Selma Cvijetić Avdagić
Croatia
Silvia Methoxha
Albania
Sjur Reppe
Norway
Stefan Mandić-Rajčević
Serbia
Sulev Koks
Australia
Susana Balcells
Spain
Susana Santos
Portugal
Tatjana Zekić
Croatia
Terhi Heino
Finland
Tilen Kranjc
Slovenia
Tõnu Esko
Estonia
Tove Borgen
Norway
Unnur Styrkársdóttir
Iceland
Vid Prijatelj
Netherlands
Vincenzo Forgetta
Canada
Wei Zhou
NL
Wim van Hul
Belgium
Wolfgang Högler
Austria
Xavier Nogues Solan
Spain
Yankel Gabet
Israel
Zoran Veličković
Serbia